Due to the controversy surrounding the term dilutional acidosis, the classical dilution concept for bicarbonate has been rigorously revised for the prediction of pH, actual bicarbonate concentration, and base excess. In the algorithms derived for buffer solutions, blood, and whole body (1-, 2-, and 3-fluid compartment), only bicarbonate is considered. On dilution at constant PCO2, the final concentration of bicarbonate is the sum in terms of pH, due to the following processes: dilution, formation from chemical reaction with the nonbicarbonate buffers phosphate, hemoglobin, and plasma proteins, and transfer from erythrocytes and interstitial fluid to plasma. At constant PCO2, the level of carbonic acid is held constant, whereas those of the buffer bases are reduced by dilution, resulting in acidosis. In mixed bicarbonate/phosphate buffer, the final concentration of HCO 3 Ϫ exceeds the diluted value due to additional buffering of H 2CO3 by HPO 4
. For whole blood in vitro, pH, and actual bicarbonate concentration are predicted from dilution with 0.9% saline from initial Hb (100%) to infinite dilution (pure saline). The acidosis from dilution of plasma bicarbonate is mitigated by contributions from plasma proteins (Ͻ1 mmol/l) and from the erythrocytes (ϳ5 mmol/l). Similarly, for whole body, the main contributions to combat primary dilutional acidosis in the range of hemodilution (relative Hb: 100-50%) are from the erythrocytes (1.2-2.2 mmol/l) and from the interstitial fluid (3.3-7.2 mmol/l). Perioperatively measured nonrespiratory acidosis is predictable if caused by hemodilution with fluids containing neither bicarbonate nor its precursors, irrespective of other electrolytes. volume expansion; volume replacement; acute normovolemic hemodilution; infusion solutions EFFECTS FROM LARGE AMOUNTS of crystalloid or colloid infusions into patients are manifold: decreased total protein ([Pr] ) and hemoglobin ([Hb] ) levels in blood and plasma, and changes in acid-base and electrolyte status. Many of the acid-base variables, pH, PCO 2 , and PO 2 , as well as many of the electrolytes, sodium, potassium, ionized calcium, chloride, and lactate, can be easily obtained by use of modern analyzing technique. Traditionally, the decrease in pH and the negative base excess (BE), e.g., from infusion of 0.9% saline, is called dilutional acidosis. In the clinical setting, however, it had generally been ignored, due to the widespread opinion that the decrease in plasma bicarbonate concentration ([HCO 3 Ϫ ]) is only small (2-3 mmol/l), compared with the large extracellular fluid (ECF) expansion (30%) (15, 17) . It was not until the nineties when the subject was rediscovered and soon became a matter of controversial discussions, both in view of the modern Stewart approach of acid-base and, conventionally, according to Henderson-Hasselbalch (HH) and Siggaard-Andersen (5, 9, 10).
The new contribution of the Stewart approach (3, 19) is the distinction between independent variables, PCO 2 , the strong ion difference (SID), and the total concentration of nonvolatile acid ([A] tot ) in the plasma, and dependent variables, pH, [HCO 3 Ϫ ], and others. The latter are completely determined by the independent variables and can only change if these are altered. For example, nonrespiratory acidosis from dilution with 0.9% saline is explained by a decrease in [A] tot , causing metabolic alkalosis, and a decrease in the SID, causing metabolic acidosis, which is prevailing (2) . In this case, dilutional acidosis is characterized by highchloride concentration (hyperchloremia) and low [HCO 3 Ϫ ] (hypobicarbonatemia) in the plasma, called hyperchloremic metabolic acidosis. It is also clear that, for prediction of plasma pH or actual [HCO 3 Ϫ ] after hemodilution at constant PCO 2 , prior predictions of the independent variables, [A] tot and SID, are necessary. For the SID, however, this comprises several ions (e.g., sodium, potassium, calcium, chloride, lactate) of which the concentrations may be decreased or increased by dilution, depending on the composition of the diluent and urinary excretion, and from movements between different compartments (plasma and erythrocytes; plasma and interstitial and intracellular fluid). Because those predictions are complex without extended measurements, HCO 3 Ϫ is preferred as a key ion, even though it is a dependent variable.
In the conventional approach of dilutional acidosis (1, 15, 16) , [HCO 3 Ϫ ] in the plasma is the basic quantity, which is decreased from dilution at constant PCO 2 . Thus, in the HH equation, the normal acid-base ratio is changed, and pH decreases. However, quantitative prediction of the pH from simple dilution fails, and the effects from saline administration in vivo, as well as from in vitro dilution of blood, plasma, and buffer solutions, were described only empirically (4) . In clinical practice, the pH, BE, and also many other variables measured in the course of hemodilution are unspecific and may include additional effects from acid-base disorders (renal, intestinal, or metabolic). This makes diagnosis often difficult and prevents critical examination of the benefits in outcome of the used resuscitation fluids.
Therefore, the classical dilution concept for HCO 3 Ϫ was reexamined and rigorously revised to allow quantitative predictions of pH, actual [HCO 3 Ϫ ], and also BE from dilution with HCO 3 Ϫ -free fluids at constant PCO 2 . In the revised dilution concept, HCO 3 Ϫ is the central and the only ion that is consequently treated as a subject of dilution, HCO 3 Ϫ formation from buffering, and redistribution by transfer between the different fluid compartments. This was demonstrated by theoretical calculations for the following systems with increasing degree of complexity (1-, 2-, and 3-fluid compartment): 1) buffer solutions, containing HCO 3 blood and whole body, the fluid compartments are red cell volume (RCV), plasma volume (PV), and interstitial fluid (ISF) volume (ISV), respectively. The large intracellular volume, other than erythrocytes, is not included and is treated only as a source of carbon dioxide for equilibration of the surrounding fluids. Both the formation of HCO 3 Ϫ from chemical reaction at constant PCO 2 in buffer solution (phosphate), plasma (protein), and erythrocytes (Hb), as well as the distribution of HCO 3 Ϫ between erythrocytes and plasma (r C ), are derived in terms of pH from known empirical equations (17, 20) , whereas the Gibbs-Donnan factor (D Ϫ ) for the distribution of HCO 3 Ϫ between ISF and plasma is assumed to be constant. For prediction of dilutional acidosis in whole body, the following input variables are needed: measured values (pH, PCO 2 
MATERIALS AND METHODS
The study was approved by the Institut für Physiologie und Pathophysiologie der Universität Mainz.
For theoretical calculations of the pH and the [HCO 3 Ϫ ] in the revised dilution concept, the following systems were considered.
The first system is hypothetical buffer solutions at the same total ionic strength (154 mmol/l): pure phosphate buffer (30 mmol/l)/NaCl (76 mmol/l), consisting of buffer base (Na 2HPO4: 24 mmol/l), and buffer acid (NaH2PO4: 6 mmol/l); pure sodium bicarbonate (24 mmol/l)/NaCl (130 mmol/l); and combined buffer of sodium bicarbonate (24 mmol/l) and phosphate (30 mmol/l)/NaCl (52 mmol/l).
The second system is whole blood in vitro: normal blood with total [Hb] (15.2 g/dl), hematocrit (0.455), and zero BE. The [Pr] was assumed to be 70 g/l. Data for comparison were taken from Zander (23) .
The third system is whole body. Data were taken from published recent clinical studies (12, 14, 18, 21) .
In the revised dilution concept, the central quantity is the [HCO 3 Ϫ ] in the solution and in the plasma for whole blood in vitro and for whole body. On dilution at constant PCO 2, it is first decreased in accordance with the dilution factor (Fdil), followed by chemical interaction of the carbonic acid with available nonvolatile buffers in the solution or in the plasma and erythrocytes to form HCO ] in the plasma is the sum of the following terms:
As shown in detail in the APPENDIX, the right side of Eq. 1 can be presented as a function, depending only on pH and known quantities. , and the second term is not zero:
Equation 4 can be given as a function of pH:
, if the HH equation is applied to the phosphate buffer with apparent pK ϭ 6.8, ] ϭ f2(pH), is obtained from Eq. 2 with apparent pK ϭ 6.1 and solubility factor ϭ 0.03 assumed for the system:
pHϪ6.1 (6) Thus, for calculation of pH and [HCO 3 Ϫ ], two equations exist, which can be solved from the condition that the difference, f1(pH) Ϫ f2(pH), must be zero. This is evaluated by numerical analysis as described in the APPENDIX.
Dilution of whole blood in vitro. The dilution of whole blood in vitro by addition of 0.9% saline (V x) to initial blood volume (BVo) at constant PCO2 is based on the assumption that only the initial PV (PVo) is diluted, whereas the initial RCV (RCVo) is not changed. Thus, in the first step of pure dilution (dil), all initial values (pHo, and hematocrit in the blood before and after dilution:
In the next step, formation of HCO 3 Ϫ from chemical reaction takes place, both in the plasma [x(P), mmol/l]: Pr Ϫ ϩ H2CO3 ϭ HPr ϩ HCO 3
Ϫ
, and in the erythrocytes [x(E), mmol/l]: HbO 2 Ϫ ϩ H2CO3 ϭ HHbO2 ϩ HCO 3 Ϫ . The concentration of formed HCO 3 Ϫ in the plasma after dilution is equal to the decrease in the proteinate concentration and is calculated according to Thomas (20) :
Similarly, in the erythrocytes, it is equal to the decrease in the oxyhemoglobinate concentration, calculated according to the equation:
The last step consists of transfer of HCO 3 Ϫ between the erythrocytes (E) and the plasma (P), until the new distribution is in accordance with the Donnan equilibrium at final plasma pH: rC ϭ [HCO 3
For rC, the distribution ratio of HCO 3 Ϫ as a function of pH, a known empirical relationship is used (17) : rC ϭ 2.642 Ϫ 0.28 ϫ pH. The final [HCO 3 Ϫ ] in the erythrocytes (E) is:
where ⌬C E is the difference between [HCO 3 Ϫ ]o and final [HCO 3 Ϫ ] in the erythrocytes if plasma pH changes from initial pHo to final pH, and in the plasma:
where the first term is the decreased [HCO 3 Ϫ ] from pure plasma dilution, the second is the increment from chemical reaction with plasma proteins, and the third is the increase from transfer of HCO 3 Ϫ produced in the erythrocytes. From combination of Eqs. 10 and 11, and substituting for r C and rearranging, ⌬CE is expressed as a function of only pH and known quantities. To calculate pH, however, a second relationship for ⌬C E must be known. This is obtained from the HH equation for the HCO 3 Ϫ /carbonic acid system in the plasma:
is substituted from Eq. 11. pH is then calculated from ⌬CE by variation of pH, until ⌬CE(1) Ϫ ⌬CE(2) is equal to zero. The detailed equations are explicitly given in the APPENDIX.
Dilution in whole body. For whole body, the two-fluid compartment for whole blood in vitro is extended to a three-fluid compartment by including the ISV. It is assumed to contain no other buffers except HCO 3 Ϫ /carbonic acid, and the distribution ratio of HCO 3 Ϫ between plasma (P) and ISF at end plasma pH is determined by the DϪ:
It is further assumed that only the ECF is diluted from volume infusion (Vx), i.e., the plasma (FP ϭ PVo/PV) and the ISF (FISF ϭ ISVo/ISV), but not the RCV. Hence, [HCO 3 
In the same way as for whole blood in vitro, the final concentration of HCO 3 Ϫ in Eq. 14 at end-plasma pH must also fulfill both the Donnan distribution equilibrium between erythrocytes and plasma (Eq. 10) and the dissociation equilibrium for HCO 3 Ϫ /carbonic acid in the plasma according to HH (Eq. 12). Hence, if substituting for ⌬CISF in Eq. 14, two equations are obtained for ⌬CE in whole body as a function of pH: ⌬CE(1) and ⌬CE(2). As above, the pH is found by variation until the condition ⌬C E(1) Ϫ ⌬CE(2) ϭ 0 is satisfied, and all of the other variables, such as BE or actual [HCO 3 with classical dilution from infusion without blood loss, initially decreased [HCO 3 Ϫ ] in the plasma is not caused from hypervolemia of the blood (BV) and ISF (ISV), but from exchange of defined blood volume out (BV out) against infused volume in (Vin). Even though this exchange is a continuous process in interaction with the surrounding ISF and the erythrocytes, the final [HCO 3 Ϫ ] at end-plasma pH is calculated in the same way as in whole body (Eqs. 13 and 14) . It is assumed that the final state at the end of ANH is the same, irrespective of whether it is reached continuously or in one step, consisting of dilution of the [HCO 3 Ϫ ]o in the plasma and in the ISF with additional formation and transfer of HCO 3 Ϫ from the erythrocytes and from the ISF to the plasma. Because decreased [Hb] is used as a measure for hemodilution ([Hb]), the F P is the same (Eq. 7) .
In all calculations, using the algorithm for dilution in whole body, BV o was estimated from known body weight by an empirical formula (7). For men, BVo (ml) ϭ 41.0 ϫ body weight (kg) ϩ 1,530, and, for women, BVo (ml) ϭ 47.16 ϫ body weight (kg) ϩ 864. In both equations, the coefficient of variation is the same: Ϯ8.9%.
RESULTS
Buffer solutions. In pure phosphate buffer (HPO 4
2Ϫ
: 24 mmol/l; H 2 PO 4 Ϫ : 6 mmol/l; total: 30 mmol/l) ( Table 1) and also in pure HCO 3 Ϫ buffer (HCO 3
Ϫ
: 24 mmol/l; CO 2 : 1.2 mmol/l; total: 25.2 mmol/l) in a closed system without gas phase, the initial pH at 7.4 is not changed after dilution (1:2) with 0.9% saline. All concentrations of the corresponding buffer pairs and also of total buffer are proportionately (1:2) decreased, and, therefore, their acid-base ratios do not change.
However, in an open system at constant PCO 2 ϭ 40 Torr, the concentration of the gaseous carbonic acid component is held permanently constant (CO 2 : 1.2 mmol/l), whereas those of the nonvolatile buffer components are reduced, resulting in acidosis (Table 1 (1:2) .
Whole blood in vitro. In the calculations, the following acid-base variables from the literature were used (23): initial pH (7.4), PCO 2 (40 Torr), and total plasma protein concentration (70 g/l) before dilution, and total Hb (15.2 g/dl) before and after dilution (10.7, 6.6, 3.7 g/dl) with 0.9% saline at constant PCO 2 . From these and the hematocrit that was calculated from the ratio of whole blood (g/dl) to MCHC (33.4 g/dl), all of the other acid-base quantities are derived ( The clinical study by Scheingraber et al. (14) featured two randomized groups of patients with gynecological surgery, blood loss, and infusion of crystalloids: 0.9% saline and lactated Ringer solution. In this case, the volumes after dilution were estimated in another way: RCV ϭ RCV o Ϫ RCV out , where RCV out ϭ BV out ⅐ Hct out is the volume of the lost erythrocytes in the 2 h of surgery and infusion, and Hct out is the mean hematocrit before (Hct o ) and after dilution (Hct); BV ϭ RCV/Hct; PV ϭ BV Ϫ RCV; ECV ϭ ECV o ϩ V in Ϫ PV out Ϫ UV, where PV out ϭ BV out ⅐ (1 Ϫ Hct out ) is the lost PV, and UV is urine volume. In both the saline and the Ringer group, all estimated volumes of the blood, plasma, and ISF are expanded and hypervolemic. ], BE, and change in (⌬) BE in the different clinical studies after infusion were calculated and compared with reported values. The agreement was good in the Hetastarch group: slight negative change in BE predicted (⌬BE: Ϫ1.81 mmol/l) and reported (⌬BE: Ϫ1.54 mmol/l); in the saline group: strongly predicted acidosis (⌬BE: Ϫ6.48 mmol/l) and reported (⌬BE: Ϫ6.61 mmol/l); and in the HES group: moderately predicted acidosis (⌬BE: Ϫ2.81 mmol/l) and reported (⌬BE: Ϫ2.38 mmol/l) ( Table 4 ). In Table  3 , the estimated volumes before and after hemodilution are within the experimental range (plus/minus %variation) of the values determined by Rehm et al. (11, 12) for plasma (Ϯ12.9%), erythrocytes (Ϯ14.6%), and blood (Ϯ11.6%), as well as for estimated total plasma protein (Ϯ7.9%) and albumin (Ϯ10.6%) concentration. If taking for calculation in the HES group the original values by Rehm et al. (12), instead of the estimated ones before and after hemodilution, the results are similar for pH, 7.322; actual HCO 3 Ϫ , 21.14 mmol/l; BE, Ϫ4.29 mmol/l; and ⌬BE, Ϫ3.29 mmol/l. However, it was contradictory in the HA group studied by Waters and Bernstein (21) , no agreement between slight changes in BE predicted (⌬BE: Ϫ1.83 mmol/l) and reported (⌬BE: ϩ0.64 mmol/l), and by Rehm et al. (12) , excellent agreement between moderately predicted acidosis (⌬BE: Ϫ2.93 mmol/l) and reported (⌬BE: Ϫ2.97 mmol/l). Also, in the Ringer group, studied by Scheingraber et al. (14) , there was no agreement: strongly predicted acidosis (⌬BE: Ϫ5.81 mmol/l) vs. reported normal BE (⌬BE: Ϫ0.48 mmol/l).
In the clinical study by Singbartl et al. (18), a great number of patients (n ϭ 127) who underwent ANH preoperatively were classified according to the mean infused volumes of a colloid solution (Haemaccel): 0, 1, 2, 3, 4, 5, and 5.5 liters. The basic values necessary for prediction of pH, plasma [HCO 3 Ϫ ], and BE were calculated in the same way as in the study by Rehm et al. (12); however, the final calculations were performed in consecutive steps without PCO 2 corrections (0 to 1, 1 to 2, 2 to 3, etc., and not 0 to 1, 0 to 2, 0 to 3, etc.) ( Table 5 ). The BV o (4.435 liters) before ANH was calculated from the mean body weight (see MATERIALS AND METHODS) and was weighted by the number of the male (n ϭ 49) and female (n ϭ 78) patients. To keep the patients normovolemic, the V in of the colloid was larger than the volume of the replaced blood (BV out ϭ V in /1.3) by ANH. In each group, the plasma lactate concentration was also measured and did not change significantly (Ͻ1 mmol/l), even under extreme hemodilution. The agreement between predicted and reported values in pH, plasma [HCO 3 Ϫ ], BE, and ⌬BE at the end of ANH is excellent.
DISCUSSION
Based on the dilution concept, nonrespiratory acidosis was predicted for all hypothetical and clinical examples treated in this study: both from dilution with 0.9% saline (simple buffer solutions, whole blood in vitro), and also in whole body from infusion with different colloid (6% HES, 5% HA, polygelatin) or crystalloid solutions (0.9% saline, lactated Ringer). It was also shown that hemodilution cannot be correctly described by simple dilution without taking into account all processes in which HCO 3 Ϫ is involved in response to addition or infusion of a diluent. However, it must be emphasized that, for all predictions, additional concentrations of the plasma electrolytes were not necessary.
The algorithm that was derived stepwise for hemodilution in whole body (3-fluid compartment) is the most general. Therefore, the algorithms for dilution of whole blood in vitro, plasma, or simple buffer solutions can be derived if the special limiting conditions are considered. For example, for HCO 3 Ϫ / phosphate buffer (1-fluid compartment), Eq. 14 reduces to [HCO 3
, by setting ISV ϭ 0, RCV ϭ 0, and replacing the HCO 3 Ϫ formation term of the plasma proteins by phosphate. For dilution in whole body, the predictions depend on the validity of several assumptions [3-fluid compartment, HCO 3 Ϫ distribution functions (r C , D Ϫ ), no HCO 3 Ϫ loss in the urine, no metabolic HCO 3 Ϫ formation, HCO 3 Ϫ -free diluents] and on the inaccuracy of the measured or estimated variables. An assumed variance in initial pH (Ϯ0.01) and in both initial and final PCO 2 (Ϯ1.5 Torr), respectively, greatly affect calculated pH (Ϯ0.010 and Ϯ0.021), plasma HCO 3 Ϫ (Ϯ0.50 and Ϯ0.72 mmol/l), and BE (Ϯ0.65 and Ϯ0.86 mmol/l), whereas those in estimated volume of blood and ECF are of minor influence. Hence, initial pH and plasma HCO 3 Ϫ were corrected for end PCO 2 (Tables 3 and 4 ). The close agreement with reported values in whole body from different clinical studies (Tables 4 and 5) indicates that the observed nonrespiratory acidosis is of dilutional origin, and, where it does not agree (lactated Ringer), it is secondary to other causes and must be diagnosed further. The dilution concept is not restricted to the HCO 3 Ϫ . If the Stewart approach is used for prediction of the dependent variables of pH or HCO 3 Ϫ after hemodilution, the SID must also be predicted from dilution. This, however, requires several ions (sodium, potassium, chloride, lactate), in contrast to the revised dilution concept, in which electrolytes other than HCO 3 Ϫ are not necessary. Dilutional acidosis. For whole blood in vitro, the extent of dilutional acidosis can be predicted from volume expansion, with 0.9% saline in the whole range from initial (15.2 g/dl) to infinite dilution. In Fig. 1 , this is expressed in a plot of plasma [HCO 3 Ϫ ] (mmol/l) vs. relative Hb (%) after hemodilution at constant PCO 2 ϭ 40 Torr. The actual concentration (first curve) is the sum of the decreased HCO 3 Ϫ from plasma dilution (second curve), plus the increment of HCO 3 Ϫ formation from the plasma proteins (fourth curve), plus the increment of HCO 3 Ϫ formation from Hb and transfer from the erythrocytes (third curve). The contributions from the plasma proteins are negligible (Ͻ1 mmol/l); only those of the erythrocytes with a broad maximum diminish the strong acidosis from pure plasma dilution. For example, in half-diluted blood (1:2), the predicted [HCO 3 Ϫ ] is 14.38 mmol/l, consisting of 8.56 mmol/l from plasma dilution (59.5%), 5.24 mmol/l from transfer from the erythrocytes (36.4%), and 0.58 mmol/l from the plasma proteins (4.0%). The percent decrease in plasma HCO 3 Ϫ (40.7%) agrees with the extrapolated value (39.8%), obtained from an empirical formula for whole blood by Garella et al. (4) . Also, the predicted BE (Ϫ13.2 mmol/l) is comparable to a recent value (Ϫ11.0 Ϯ 2.2 mmol/l) from dilution of blood with 0.9% saline (BE ϭ 1.4506⅐[Hb] Ϫ 22.47) (8) .
In a similar plot, acidosis from hemodilution in whole body under extreme ANH with colloid solution under normocapnic conditions is demonstrated in Fig. 2 . The points on the fourth curve describe the decreased plasma [HCO 3 Ϫ ] from pure plasma dilution, to which the negligible fractions from the plasma proteins (Ͻ1 mmol/l) are successively added, from the erythrocytes (1.2-2.2 mmol/l), and from the ISF (3.3-7.2 mmol/l). In the range of hemodilution (relative Hb, 100 -50%), no maxima can be observed in the contributions from the erythrocytes or from the ISF. The BE is negative for all groups, and the changes in BE under extreme hemodilution ([Hb] ϭ 5.93 g/dl), predicted (Ϫ7.56 mmol/l) and reported (Ϫ7.46 mmol/l), obviously were not caused by lactic acidosis from oxygen deficit, but from dilution by volume replacement. The corresponding decrease in plasma Colloid solution (Haemaccel) contained 35 g/l polygelatin, 145 mmol/l sodium, 5.1 mmol/l potassium, 6.25 mmol/l calcium, and 145 mmol/l chloride. No. of patients ϭ 127; mean age ϭ 65 Ϯ 13 yr; mean body weight ϭ 74 Ϯ 13 kg; total plasma protein ϭ 62 g/l assumed. ECV is estimated 0.2 from body weight; Hct is calculated from measured Hb (g/dl); BVout is estimated blood loss (Vin/1.3); Vin, infused volume; ⌬BE is before and after hemodilution. Infusion solutions and prevention of dilutional acidosis. When dilutional acidosis was verified by experimental evidence in dogs from isotonic solutions, irrespective of whether they contained chloride or not (1) , it was also demonstrated that this could be prevented by infusion of balanced (16) . The acid-base effects observable from infusion on whole body greatly depend on composition of the administered fluid, as well as on its volume and rate. Hence, it is surprising that infusion solutions are badly characterized with respect to their actual acid-base properties in the body. In recent time, two attempts have been made: the one proposed by Zander (22) , who transferred the conventional BE concept to infusion solutions, including also metabolic effects from HCO 3 Ϫ precursors such as lactate, citrate, or acetate by an additional term, called the potential BE; the other proposed by Morgan et al. (8) , who used the SID concept. By the latter declaration, however, the clinical implications are not always immediately comprehensible if the [HCO 3 Ϫ ] is not explicitly given. This is the case, e.g., in hypoproteinemic alkalosis, which is explained by a decrease in the plasma proteins, and the in vitro data of human blood from Rossing et al. (13) have been frequently cited. In the plasmalike diluent (in mmol/l: 143 Na ϩ , 3.9 K ϩ , 108 Cl Ϫ , 39 total CO 2 ), the SID (Na ϩ K Ϫ Cl) is 38.9 mmol/l and equals approximately the sum of the HCO 3 Ϫ ϩ the proteinate concentration, if present in the solution. To a clinician, however, who is aware of 38.9 mmol/l of HCO 3 Ϫ in the solution, alkalosis is not surprising.
In the chosen clinical studies, all infusion solutions contained high-sodium (Ͼ142 mmol/l) and high-chloride (Ͼ102 mmol/l) concentrations, except for lactated Ringer solution (in mmol/l: 130 Na ϩ , 112 Cl Ϫ , and 27 lactate) by Scheingraber et al. (14) and 5% albumin solution by Waters and Bernstein (21) , suspected to contain HCO 3 Ϫ of unknown amounts (in mmol/l: 150 Na ϩ , 93 Cl Ϫ , and Ͻ50 HCO 3 Ϫ ). For the latter two solutions, however, acidosis was predicted, in contrast to the reported normal acid-base state. These obvious discrepancies are good examples, demonstrating how the dilution concept can successfully be applied. Because in the organism HCO 3 Ϫ can be metabolically generated from lactate, lactated Ringer solution is only apparently HCO 3 Ϫ free. Analyzing the acidbase state before and after infusion with lactated Ringer solution, the difference in ⌬BE between actual (Ϫ0.48) and predicted (Ϫ5.81) is ϩ5.33 mmol/l. Hence, the amount of base to compensate for dilutional acidosis in the Ringer group must be 82.5 mmol [ϭ 0.2⅐BE (mmol/l)⅐body weight (kg)]. From a simple balance of converted and total infused lactate (5.2 l ϫ 27 mmol/l ϭ 140 mmol) at the end of 2 h, the concentration of lactate in the ECF (19.0 liter) is ϳ3.1 mmol/l, close to the measured plasma concentration of 2.0 mmol/l. Hence, iatrogenically caused dilutional acidosis was compensated by induced alkalinizing hepatic metabolism, which is the strategy of this widely used solution in preventing nonrespiratory acidosis. However, most solutions for use in clinical practice are not physiological (high chloride; no HCO 3 Ϫ ) and are often a compromise due to the manufacturing conditions (sterility, stability, costs). This must lead to additional acid-base effects (dilutional acidosis, rebound alkalosis from metabolizable anions), if such solutions are administered into patients in large amounts. In the case of dilutional acidosis caused from HCO 3 Ϫ -free solutions, irrespective of whether they contain chloride or not, measured plasma chloride concentration may be used for additional characterization as hyper-or hypochloremic. Substituting in Eq. A4 for pH(E) and inserting MCHC ϭ 20.7 mmol/l, the change in plasma pH from initial pH o to final pH yields Eq. 9, but without the negative sign.
APPENDIX

Equations for Calculation of
Complete Equations for ⌬C E of whole blood in vitro
From combination of Eqs. 10 and 11 and rearranging, ⌬CE(1) is explicitly given: Ϫ (E) from plasma dilution, plus the increments from the plasma proteins (Pr), the erythrocytes (E), and the interstitial fluid (ISF) with corresponding buffers.
All quantities are known from the baseline data and as a function of plasma pH. The empirical relationship for the distribution ratio of HCO 3 Ϫ as a function of pH is taken from Siggaard-Andersen (17) and was linearized: r C ϭ 0.57 Ϫ 0.28 ϫ (pH Ϫ 7.4) ϭ 2.642 Ϫ 0.28 ϫ pH.
Similarly, introduction of Eq. 11 into the HH Eq. 12 yields ⌬CE (2): In all calculations, the ratio RCV/PV is replaced by the hematocrit: Hct/(1 Ϫ Hct).
Complete Equations for ⌬C E in Whole Body
From distribution of HCO 3 Ϫ between ISF and plasma (P): 
From distribution of HCO 3 Ϫ between erythrocytes (E) and plasma (P), and substituting for ⌬CISF into Eq. 14:
and from the HH Eq. 12 :
